AU2001272558A1 - Method for identifying metastatic tumor cells - Google Patents

Method for identifying metastatic tumor cells

Info

Publication number
AU2001272558A1
AU2001272558A1 AU2001272558A AU7255801A AU2001272558A1 AU 2001272558 A1 AU2001272558 A1 AU 2001272558A1 AU 2001272558 A AU2001272558 A AU 2001272558A AU 7255801 A AU7255801 A AU 7255801A AU 2001272558 A1 AU2001272558 A1 AU 2001272558A1
Authority
AU
Australia
Prior art keywords
tumor cells
metastatic tumor
identifying metastatic
identifying
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001272558A
Other languages
English (en)
Inventor
Peter Herrlich
Martin Hofmann
Andrea Nestl
Jonathan Sleeman
Oliver Von Stein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Forschungszentrum Karlsruhe GmbH
Original Assignee
Forschungszentrum Karlsruhe GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forschungszentrum Karlsruhe GmbH filed Critical Forschungszentrum Karlsruhe GmbH
Publication of AU2001272558A1 publication Critical patent/AU2001272558A1/en
Assigned to FORSCHUNGSZENTRUM KARLSRUHE GMBH reassignment FORSCHUNGSZENTRUM KARLSRUHE GMBH Amend patent request/document other than specification (104) Assignors: FORSCHUNGSZENTRUM KARLSRUHE GMBH TECHNIK UND UMWELT
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001272558A 2000-07-25 2001-07-24 Method for identifying metastatic tumor cells Abandoned AU2001272558A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10036126 2000-07-25
DE10036126.9 2000-07-25
PCT/EP2001/008517 WO2002008456A2 (de) 2000-07-25 2001-07-24 Verfahren zur identifizierung metastasierender tumorzellen

Publications (1)

Publication Number Publication Date
AU2001272558A1 true AU2001272558A1 (en) 2002-02-05

Family

ID=7650102

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001272558A Abandoned AU2001272558A1 (en) 2000-07-25 2001-07-24 Method for identifying metastatic tumor cells

Country Status (7)

Country Link
US (1) US20040265804A1 (de)
EP (1) EP1356095A2 (de)
JP (1) JP2004515221A (de)
AU (1) AU2001272558A1 (de)
CA (1) CA2416697A1 (de)
DE (1) DE10135996A1 (de)
WO (1) WO2002008456A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6893818B1 (en) 1999-10-28 2005-05-17 Agensys, Inc. Gene upregulated in cancers of the prostate
DE10229391A1 (de) * 2002-06-29 2004-01-29 Forschungszentrum Karlsruhe Gmbh METASTACHIP: ein Biochip zur Bestimmung des metastatischen Potentials von Tumoren
DE10242663A1 (de) * 2002-09-13 2004-03-25 Forschungszentrum Karlsruhe Gmbh Verfahren zur Identifizierung von Inhibitoren in vivo

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU625169B2 (en) * 1987-03-23 1992-07-02 Imperial Chemical Industries Plc Molecular markers
US5539096A (en) * 1994-09-08 1996-07-23 Universite De Montreal Genes differentially expressed in metastatic and non-metastatic rat rhabdomyosarcoma cell lines
WO1999065928A2 (en) * 1998-06-19 1999-12-23 Genzyme Corporation Polynucleotide population isolated from non-metastatic and metastatic breast tumor tissues
DE69938190T2 (de) * 1998-10-15 2009-03-05 Novartis Vaccines and Diagnostics, Inc., Emeryville Gene mit veränderter expression in metastatischen brust- oder dickdarm- krebszellen
US6504010B1 (en) * 1999-06-30 2003-01-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer

Also Published As

Publication number Publication date
US20040265804A1 (en) 2004-12-30
CA2416697A1 (en) 2003-01-24
EP1356095A2 (de) 2003-10-29
DE10135996A1 (de) 2002-03-28
WO2002008456A2 (de) 2002-01-31
WO2002008456A8 (de) 2002-07-11
WO2002008456A3 (de) 2003-09-04
JP2004515221A (ja) 2004-05-27

Similar Documents

Publication Publication Date Title
AU2001227966A1 (en) Methods for treating tumors
AU3448400A (en) Method for communicating information
AU2001273503A1 (en) A method for prognosing cancer and the proteins involved
AU2001289177A1 (en) Method for determining alleles
AU2002307466A1 (en) Method for detecting breast cancer cells
AU2308900A (en) Analysis method
AU1409700A (en) Method for counting living cells
AU2001229461A1 (en) Method for inhibiting a tumor
AU7203701A (en) Assaying method
AU2881301A (en) Cancer cell implantation inhibitors
AU5867901A (en) Method for detecting tumors
AU2001263751A1 (en) Rotating method
AU3981799A (en) Method for identifying genes
AU2001237530A1 (en) Method
AU2001272558A1 (en) Method for identifying metastatic tumor cells
AU2001241636A1 (en) Halotherapy method
AU4056500A (en) Methods for detecting cancer cells
AU2002220757A1 (en) Method for obtaining azaerythromycin
AU2635001A (en) Polynucleotides for inhibiting metastasis and tumor cell growth
AU2001280916A1 (en) Methods for identifying genomic deletions
AU2001287744A1 (en) Method for detecting tumor cells
AU2001290241A1 (en) Tumor cell proliferation inhibitors
AU4131999A (en) Detection method for tumor cells
AU2001232127A1 (en) Identification method
AU2002228975A1 (en) Method

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted